Related Experiment Video
Updated: May 20, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Long-term oncological outcomes after laparoscopic radical prostatectomy
Marcel Hruza1, Justo Lorenzo Bermejo, Bettina Flinspach
1Department of Urology, SLK-Kliniken, Heilbronn, Germany. marcel.hruza@gmail.com
BJU International
|July 5, 2012
Summary
Laparoscopic radical prostatectomy (LRP) offers high 10-year survival rates for prostate cancer. Gleason score and pT stage are key predictors of recurrence-free survival after LRP.
Area of Science:
- Urology
- Surgical Oncology
- Oncology
Background:
- Laparoscopic radical prostatectomy (LRP) is a minimally invasive surgical option for prostate cancer.
- Assessing long-term oncological outcomes is crucial for evaluating surgical techniques.
Purpose of the Study:
- To evaluate long-term oncological outcomes following LRP.
- To identify prognostic factors for recurrence-free survival after LRP.
Main Methods:
- Prospective data collection on 500 patients undergoing LRP using the Heilbronn technique.
- Analysis of biochemical recurrence-free survival (BCRFS) using Kaplan-Meier and Cox regression.
- Adjuvant therapy guided by an institutional algorithm for high-risk patients.
Main Results:
- Ten-year BCRFS rates were 80.2% (pT2), 47.4% (pT3a), and 49.8% (pT3b/4).
- Gleason score and pT stage were significant predictors of BCRFS in multivariate analysis.
- Ten-year clinical progression-free survival and prostate cancer-specific survival rates were high across all stages.
Conclusions:
- LRP, combined with risk-adapted adjuvant therapy, yields favorable long-term oncological outcomes.
- Laparoscopic techniques demonstrate comparable oncological results to open retropubic radical prostatectomy.
- Gleason score and pT stage are critical determinants of recurrence-free survival post-LRP.
